Fidelity Select Pharmaceuticals Portfolio (FPHAX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
31.03
+0.91 (3.02%)
Apr 1, 2026, 8:10 AM EST
FPHAX Holdings Information
FPHAX is a mutual fund with a total of 60 individual holdings. The top holdings are Eli Lilly and Company stock at 24.22%, AstraZeneca at 11.10%, Johnson & Johnson at 8.91%, Gilead Sciences at 5.45%, and GSK plc at 5.07%.
Total Holdings
60
Top 10 Percentage
75.53%
Asset Class
Equity
Fund Category
Health
Assets
1.52B
Forward PE Ratio
19.28
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 24.22% |
| 2 | AZN | AstraZeneca PLC | 11.10% |
| 3 | JNJ | Johnson & Johnson | 8.91% |
| 4 | GILD | Gilead Sciences, Inc. | 5.45% |
| 5 | GSK | GSK plc | 5.07% |
| 6 | SWX: ROG | Roche Holding AG | 5.00% |
| 7 | EBR: UCB | UCB SA | 4.85% |
| 8 | MRK | Merck & Co., Inc. | 4.33% |
| 9 | ELAN | Elanco Animal Health Incorporated | 4.27% |
| 10 | JAZZ | Jazz Pharmaceuticals plc | 2.35% |
| 11 | RPRX | Royalty Pharma plc | 2.19% |
| 12 | MRNA | Moderna, Inc. | 2.12% |
| 13 | LEGN | Legend Biotech Corporation | 1.99% |
| 14 | EBR: TUB | Financière de Tubize SA | 1.63% |
| 15 | QURE | uniQure N.V. | 1.53% |
| 16 | BNTX | BioNTech SE | 1.05% |
| 17 | ETR: MRK | Merck KGaA | 0.99% |
| 18 | BIIB | Biogen Inc. | 0.92% |
| 19 | OCUL | Ocular Therapeutix, Inc. | 0.85% |
| 20 | PTCT | PTC Therapeutics, Inc. | 0.82% |
| 21 | XENE | Xenon Pharmaceuticals Inc. | 0.77% |
| 22 | AXSM | Axsome Therapeutics, Inc. | 0.63% |
| 23 | BEAM | Beam Therapeutics Inc. | 0.61% |
| 24 | CAPR | Capricor Therapeutics, Inc. | 0.60% |
| 25 | ANNX | Annexon, Inc. | 0.55% |
As of Jan 31, 2026